ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

First, select a broad health condition.
31619 results sorted by trial registration date.
Clear all

  • An exploration of the immunomodulatory, anti-inflammatory and antioxidant activities of bovine lactoferrin in healthy males (a pilot study)

    The study explored the degree of safety and efficacy of a bovine lactoferrin supplement on healthy males by evaluating the in vivo and ex vivo changes of antioxidant and various immune cell functions.

    Registration number:
    ACTRN12605000289617
    Broad health category:
    • Inflammatory and Immune System
    Specific health category:
    • Normal development and function of the immune system
    Trial focus:
    • Treatment
    Recruitment status:
    • Completed
    Recruitment sites:
    • Not specified
    Gender:
    • All

  • Study on the Safety and Efficacy of Sylvan Red Yeast Rice in Adults with Primary Hypercholesterolemia

    This stage is a randomised, double blind, placebo-controlled, three arm parallel study. The study will compare baseline lipid levels with post-treatment levels for the treatment and placebo groups over a 12-week period. Interim analyses of the data will be conducted at the completion of stage 1, and subjects will be issued with the active medication at the end of week 12. The analysis of data will continue for 8 weeks. Stage 2 continued as an open label trial for 40 weeks and stage 3 continued as an open label trial for a further 48 weeks.

    Registration number:
    ACTRN12605000288628
    Broad health category:
    • Diet and Nutrition
    Specific health category:
    • Other diet and nutrition disorders
    Trial focus:
    • Treatment
    Recruitment status:
    • Completed
    Recruitment sites:
    • Not specified
    Gender:
    • All

  • Analysis of the effect of a 6 week very low calorie diet (VLCD) on patients at high risk of NASH as shown by changes of liver biopsy, liver biochemistry and CT scan.

    Registration number:
    ACTRN12605000287639
    Broad health category:
    • Diet and Nutrition
    • Inflammatory and Immune System
    Specific health category:
    • Not specified
    • Other inflammatory or immune system disorders
    Trial focus:
    • Not specified
    Recruitment status:
    • Recruiting
    Recruitment sites:
    • Not specified
    Gender:
    • All

  • The AustraliaN Trial Investigating Post Operative Deficit, Early extubation and Survival (ANTIPODES)

    Registration number:
    ACTRN12605000285651
    Broad health category:
    • Surgery
    • Anaesthesiology
    • Mental Health
    Specific health category:
    • Other surgery
    • Anaesthetics
    • Studies of normal psychology, cognitive function and behaviour
    Trial focus:
    • Prevention
    Recruitment status:
    • Completed
    Recruitment sites:
    • Not specified
    Gender:
    • All

  • A prospective observational study of the effect of a pre-operative 12 week very low calorie diet (VLCD) on liver volume and intra-abdominal fat mass in severely obese patients presenting for obesity surgery.

    Registration number:
    ACTRN12605000284662
    Broad health category:
    • Diet and Nutrition
    • Surgery
    Specific health category:
    • Obesity
    • Other surgery
    Trial focus:
    • Not specified
    Recruitment status:
    • Completed
    Recruitment sites:
    • Not specified
    Gender:
    • All

  • Testosterone in Obese Men Trial

    Registration number:
    ACTRN12605000283673
    Broad health category:
    • Diet and Nutrition
    • Metabolic and Endocrine
    Specific health category:
    • Obesity
    • Other metabolic and endocrine disorders
    Trial focus:
    • Treatment
    Recruitment status:
    • Recruiting
    Recruitment sites:
    • Not specified
    Gender:
    • All

  • ANZ 02P2 / International Breast cancer Intervention Study: IBIS-II DCIS

    Phase 3 This study is comparing the effectiveness of the drugs tamoxifen versus anastrozole in postmenopausal women with hormone sensitive ductal carcinoma in situ (DCIS). This is an ANZ 02P2/ International Breast Cancer Intervention Study: IBIS-II DCIS. Who is it for? You can join this trial if: You are a postmenopausal woman aged between 40 and 70 years. You must have had DCIS diagnosed in one breast within the last 6 months. The DCIS must have been hormone sensitive and have been locally removed (i.e.not by mastectomy). Trial details Participants will be randomly divided into two groups. One group receives tamoxifen plus a non-active compound in place of anastrozole. The other group receives anastrozole plus a non-active compound in place of tamoxifen. These are taken orally, every day for 5 years. The study aims to compare how effective the two drugs are in preventing and controlling locally any subsequent disease, in the same or the other breast. DCIS has the potential to develop into breast cancer which can spread to other places in the body. Both tamoxifen and anastrozole lower levels of the hormone oestrogen in the body and are used in women already diagnosed with breast cancer. Tamoxifen is used in some women with DCIS for the prevention of breast cancer. This trial is looking at whether anastrozole is as effective as tamoxifen in preventing further DCIS and breast cancer.

    Registration number:
    ACTRN12605000282684
    Broad health category:
    • Cancer
    Specific health category:
    • Breast
    Trial focus:
    • Prevention
    Recruitment status:
    • Completed
    Recruitment sites:
    • NSW
    • VIC
    • QLD
    • SA
    • WA
    Gender:
    • All

  • Does a six-week stretching program change the extensibility of the hamstring muscle ?

    Randomised Conrolled Trial looking at effectiveness of 6 weeks of daily 30-minute stretch intervention on hamstring muscle extensibility in able-bodied population

    Registration number:
    ACTRN12605000281695
    Broad health category:
    • Musculoskeletal
    Specific health category:
    • Normal musculoskeletal and cartilage development and function
    Trial focus:
    • Treatment
    Recruitment status:
    • Recruiting
    Recruitment sites:
    • Not specified
    Gender:
    • All

  • Isocapnic intermittent hypoxia and endothelial dysfunction

    Registration number:
    ACTRN12605000280606
    Broad health category:
    • Other
    Specific health category:
    • Not specified
    Trial focus:
    • Diagnosis
    Recruitment status:
    • Recruiting
    Recruitment sites:
    • Not specified
    Gender:
    • All

  • Interventions to improve participation in bowel cancer screening: the value of lay advocacy and positive framing of risk.

    Improved participation in screening for bowel cancer is desirable. Currently population scale bowel cancer screening program delivery is by mailed offer from a central screening service and invitations include a faecal occult blood detection kit. Invitees may decline the offer because they do not feel they are at risk, or because they do not engage with the program. We have developed invitation letters to that include either improved risk messages or messages from previous screening participants in order to overcome these barriers. We will randomly select invitees from the electoral roll and compare population screening participation between groups with or without the preliminary letter to determine which program results in the greater participation rate. Improved participation in screening will ultimately reduce deaths from bowel cancer

    Registration number:
    ACTRN12605000279628
    Broad health category:
    • Cancer
    Specific health category:
    • Bowel - Anal
    • Bowel - Back passage (rectum) or large bowel (colon)
    • Bowel - Small bowel (duodenum and ileum
    Trial focus:
    • Prevention
    Recruitment status:
    • Active, not recruiting
    Recruitment sites:
    • Not specified
    Gender:
    • All
Tags:
  • Finding clinical trials